TXT
60
2
AMAT
55
6
MCO
78
3
NFLX
58
3
SLG
64
-2
PGR
65
-3
SWN
73
3
DLTR
28
-3
AMG
44
3
GT
50
4
CHK
35
8
UA
24
-9
ROP
65
6
CMA
64
5
SJM
41
8
PWR
67
7
APH
53
5
USB
47
4
MOS
23
3
DE
45
5
TXT
60
2
AMAT
55
6
MCO
78
3
NFLX
58
3
SLG
64
-2
PGR
65
-3
SWN
73
3
DLTR
28
-3
AMG
44
3
GT
50
4
CHK
35
8
UA
24
-9
ROP
65
6
CMA
64
5
SJM
41
8
PWR
67
7
APH
53
5
USB
47
4
MOS
23
3
DE
45
5
Financhill
Back

Catalyst Pharmaceuticals Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
49

CPRX
Catalyst Pharmaceuticals

Last Price:
20.75
Seasonality Move:
-9.09%
Sell
49

RARE
Ultragenyx Pharmaceutical

Last Price:
58.74
Seasonality Move:
-0.7%
Sell
49
Catalyst Pharmaceuticals (CPRX) is a Sell

Is Catalyst Pharmaceuticals a Buy, Sell or Hold?

  • The current Catalyst Pharmaceuticals [CPRX] share price is $21.36. The Score for CPRX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $58.77. The Score for RARE is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CPRX Stock Price Chart

What is Catalyst Pharmaceuticals's stock price today?

  • The Catalyst Pharmaceuticals share price today is $21.36
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $58.77
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight selling pressure.

CPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.5 Buy
Relative Strength Index (14 RSI): 70.42 Buy
Chaikin Money Flow: 901932 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.72 - 20.62) Buy
Bollinger Bands (100): (15.22 - 19.16) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.9 Buy
Relative Strength Index (14 RSI): 65.66 Buy
Chaikin Money Flow: -154927 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.53 - 58.27) Buy
Bollinger Bands (100): (39.73 - 52.87) Buy

CPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.25 Buy
20-day SMA: 20.17 Buy
50-day SMA: 18.73 Buy
200-day SMA: 16.16 Buy
8-day EMA: 20.45 Buy
20-day EMA: 20.02 Buy
50-day EMA: 18.92 Buy
200-day EMA: 16.55 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.87 Buy
20-day SMA: 57.08 Buy
50-day SMA: 51.49 Buy
200-day SMA: 46.42 Buy
8-day EMA: 57.94 Buy
20-day EMA: 56.47 Buy
50-day EMA: 52.53 Buy
200-day EMA: 46.74 Buy

Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.10 per share, an increase this year of $0.05 per share, and an increase next year of $0.20 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.53 per share, an increase next quarter of $0.18 per share, an increase this year of $1.07 per share, and an increase next year of $1.02 per share.

Catalyst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):